Analysis of dermatomyositis-specific autoantibodies and clinical characteristics in Japanese patients

Myositis autoantibodies in Korean patients with inflammatory myositis: Anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis

(2010) Eun Ha Kang et al.   BMC MUSCULOSKELETAL DISORDERS

Cancer-Associated Myositis and Anti-p155 Autoantibody in a Series of 85 Patients With Idiopathic Inflammatory Myopathy

(2010) Ernesto Trallero-Araguás et al.   MEDICINE

Anti-MDA5 and anti-TIF1-γ antibodies have clinical significance for patients with dermatomyositis

(2010) Kei Hoshino et al.   RHEUMATOLOGY

RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease

(2009) Shinji Sato et al.   ARTHRITIS AND RHEUMATISM

Association of distinct clinical subsets with myositis‐specific autoantibodies towards anti‐155/140‐kDa polypeptides, anti‐140‐kDa polypeptides, and anti‐aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single‐centre, cross‐sectional study

(2009) K. Fujikawa et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Newly identified autoantibodies: relationship to idiopathic inflammatory myopathy subsets and pathogenesis

(2008) Harsha Gunawardena et al.   CURRENT OPINION IN RHEUMATOLOGY

Autoantibodies and their significance in myositis

(2008) Ira N. Targoff   Current Rheumatology Reports